– Jonathan Kimmelman, Ph.D., Assistant Professor in the Biomedical Ethics Unit/Social Studies of Medicine Department, McGill University

PodcastsResourcesClinical trialDrug research and developmentPharmacologySoftwareTechnology and Computational Biology
Previous articleCovance Takes Over Lilly’s Greenfield, Indiana Site for $50M and Gains $1.6B Contract
Next articleMiraculins Gains Rights to Mount Sinai Biomarkers for Preeclampsia